Western University has announced that it will be taking part in the DISCOVER-ME collaboration led by MedUni Vienna, which is focused on the diagnosis and treatment of myalgic encephalomyelitis/chronic fatigue syndrome. Western says that it is the only institution outside of Europe taking part in the collaboration, which is supported by €7.5M from the European Union’s Horizon Europe program. As one of the key analytical hubs, the university will support the analysis of blood samples with advanced machine learning and AI. “Being invited to join this international consortium is an incredible opportunity for Western to help uncover the biological causes of ME/CFS and accelerate the development of new, more effective treatments,” said Western GSK Chair in Clinical Pharmacology Douglas Fraser.
